NASDAQ:GBT

Global Blood Therapeutics Earning Date

USA |NASDAQ |USD

GBT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-1.11 $-1.12 $-0.97
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $53.68M $47.55M $36.89M

Global Blood Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

GBT Earnings Date & History Chart

GBT Earnings & Revenue Forecast

GBT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 21 $-1.07 $-1.42 $-0.65
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 22 $-4.50 $-5.13 $-3.92
Dec 2022 21 $-3.23 $-5.01 $0.11

GBT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-1.07 $-1.07 $-1.09
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 1 $-4.51 $-4.51 $-4.60
Dec 2022 1 / 0 $-3.13 $-3.13 $-3.03

GBT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 19 $60.71M $53.00M $80.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 21 $200.80M $192.40M $226.60M
Dec 2022 21 $329.99M $255.50M $497.20M

GBT Earnings Date & Revenue History

GBT Earnings History

|
Show More
Show More

GBT Revenue History

|
Show More
Show More

Global Blood Therapeutics Next Earnings Date & Report

GBT Next Earnings Date & Report Preview: Sep 2021 (FQ)

GBT's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 21 analysts, the average EPS estimation for Global Blood Therapeutics's next quarterly earnings is $-1.11, with a low EPS estimation of $-1.38, and a high estimation of $-0.94.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-1.11, the last 2 month trend is $-1.11, and the 3 month trend is $-1.13.

Based on 18 analysts, the average revenue estimation is $53.68M, with a low revenue estimation of $51.90M, and a high estimation of $60.00M.

Global Blood Therapeutics Previous Earnings Dates & Reports

GBT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Global Blood Therapeutics's previous earnings date was Aug 3, 2021 for its fiscal quarter ended Jun 30, 2021.

GBT's earnings per share (EPS) was $-1.12, beating the consensus analysts forecast of $-1.18 by 4.83%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -7.44%, and lower than the same period a year before (Jun 2020) by 30.23%.

Revenues were $47.55M, better than the forecast of $43.92M by 8.28%, up by 21.80% from the previous quarter , and up by 50.96% from the same period last year.

The company reported a net income of $-69.59M.

Free cash flow for the quarter was $-45.11M , compared to $-80.39M last quarter and $-48.88M a year before.

GBT ended the quarter with $230.95M in total debt, a decrease of -0.43% compared to the previous quarter, and an increase of 0.51% compared to the same quarter a year before.

GBT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Global Blood Therapeutics's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

GBT's earnings per share (EPS) was $-4.05, missing the consensus analysts forecast of $-3.99 by 1.38% , and higher than the previous year's EPS (Dec 2019) by -13.52%.

Revenues were $123.80M, better than the forecast of $121.44M by 1.95%, and up by 5773.01% from previous year's revenue.

The company reported a net income of $-247.55M.

Global Blood Therapeutics reported a free cash flow of $-220.62M for its fiscal year, compared to $-197.88M a year ago.

The company ended the fiscal year with $153.65M in total debt, an increase of 103.71% compared to the previous year.